Candida auris admission screening pilot in select units of New York City health care facilities, 2017-2019
Description
Candida auris (C. auris), first described in 2009 in Japan, is a multidrug-resistant yeast and a source of health care-associated outbreaks globally, including the United States.1-6 C. auris causes a spectrum of conditions, from colonization to